Agilent to buy digital pathology firm Proscia for up to $270M

Agilent Technologies agreed to acquire Proscia, a provider of enterprise digital pathology software for clinical and life-sciences customers, in an all-cash deal worth $240 million at closing. Up to another $30 million is payable if future performance milestones are met.

Why it matters: Agilent is adding AI-enabled software to its pathology lineup as labs digitize slide review.